- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- May 04, 2024, 12:31:14 PM
- Local Time:
- May 18, 2024, 12:24:32 PM
- Last Active:
- May 04, 2024, 04:00:53 PM
Signature:
The particular % differ from base line throughout VAS and also Simpl standing with week 07 was in favour of nemolizumab in most subgroups based on bas